Agent for preventing onset of idiopathic osteonecrosis of femoral head and/or suppressing progress of same
AssigneesAsahi Kasei Pharma Corporation, National University Corporation Asahikawa Medical University
InventorsHiromasa Tanino, Hiroshi Ito
Life of this patent
Estimating the term…
Abstract
[Problem] To provide an agent for preventing the onset of idiopathic osteonecrosis of the femoral head and/or suppressing the progress of the same. [Solution] An agent for preventing the onset of idiopathic osteonecrosis of the femoral head and/or suppressing the progress of the same comprising parathyroid hormone or a derivative thereof as an active ingredient, characterized by being administered intermittently.
Claims9
A method for treating idiopathic osteonecrosis of the femoral head and/or suppressing the progress of the same in a patient in need thereof, comprising:
- administering intermittently to the patient an effective amount of an agent comprising parathyroid hormone or a derivative thereof as an active ingredient,
- wherein 56.5 μg/time of said parathyroid hormone or derivative thereof is administered once a week.
A method for suppressing femoral head collapse in a patient having idiopathic osteonecrosis of the femoral head, comprising:
- administering intermittently to the patient an effective amount of an agent comprising parathyroid hormone or a derivative thereof as an active ingredient,
- wherein 56.5 μg/time of said parathyroid hormone or derivative thereof is administered once a week.
Dependencies are inferred from the claim text.